| CASE REPORT |
|
| Year : 2014 | Volume
: 6
| Issue : 2 | Page : 82-85 |
|
|
Intravenous immunoglobulin in the treatment of severe Clostridium difficile colitis
Nihar Shah1, Hamid Shaaban2, Robert Spira1, Jihad Slim1, Jack Boghossian1
1 Department of Gastroenterology, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA
2 Department of Infectious Diseases, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey, USA
Correspondence Address:
Dr. Hamid Shaaban
Department of Infectious Diseases, Saint Michael's Medical Center, School of Health and Medical Sciences, Seton Hall University, New Jersey
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-777X.132053
|
|
|
Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
